largest
outbreak
ebola
viru
diseas
began
guinea
west
africa
decemb
rapidli
spread
major
popul
center
west
african
countri
earli
report
scientif
public
media
specul
viru
evolv
effect
transmit
human
one
rout
transmiss
postul
aerosol
transmiss
although
littl
epidemiolog
evid
support
claim
studi
investig
viabil
zair
ebolaviru
strain
within
aerosol
rel
humid
time
result
present
indic
differ
viru
stabil
strain
viabl
viru
recov
aerosol
minut
gener
largest
outbreak
ebola
viru
diseas
date
quietli
began
decemb
first
case
guinea
west
africa
august
diseas
becom
establish
larg
popul
center
guinea
sierra
leon
liberia
rapid
spread
zair
ebolaviru
ebov
makona
strain
wide
geograph
rang
led
question
increas
virul
humantohuman
transmiss
circul
variant
viru
involv
epidem
sequenc
analysi
earli
viru
isol
collect
patient
guinea
sierra
leon
conduct
attempt
determin
whether
makona
strain
chang
rapidli
strain
previou
outbreak
critic
inform
diagnost
assay
depend
sequenc
assay
reagent
match
sequenc
circul
virus
first
sequenc
analysi
show
west
african
strain
viru
form
clade
distinct
ebov
sequenc
collect
previou
outbreak
central
africa
analysi
new
sequenc
nucleotid
level
reveal
differ
among
sequenc
analyz
substitut
rate
twice
rate
outbreak
addit
substitut
often
nonsynonym
howev
studi
includ
ebov
sequenc
cover
larger
tempor
spatial
distribut
show
lower
rate
viru
evolut
nucleotid
mutat
synonym
occur
noncod
region
similar
observ
previou
outbreak
patholog
ebola
viru
diseas
induc
via
inhal
aerosol
extens
studi
nonhuman
primat
sinc
lethal
outcom
use
method
demonstr
rhesu
cynomolgu
macaqu
ebola
viru
sudan
viru
marburg
viru
gener
accept
condit
must
met
natur
aerosol
transmiss
occur
infect
individu
must
abl
produc
aerosol
contain
viabl
viru
high
enough
concentr
infecti
aerosol
viru
must
remain
viabl
long
enough
come
contact
suscept
individu
viabl
viru
must
abl
infect
suscept
individu
point
contact
current
studi
focus
second
conditionst
viru
within
aerosol
viru
surviv
extend
time
within
aerosol
increas
risk
enhanc
transmiss
individu
test
possibl
west
african
ebov
strain
stabl
within
aerosol
histor
strain
compar
aerosol
stabil
ebov
isol
mayinga
outbreak
strain
isol
guinean
patient
earli
west
african
outbreak
ebola
viru
ebola
viru
use
describ
elsewher
stock
cultur
dilut
dulbecco
minimum
essenti
medium
dmem
supplement
fetal
bovin
serum
fb
mmoll
lglutamin
work
use
virus
conduct
class
type
iia
biosafeti
cabinet
within
biosafeti
level
laboratori
ebola
virus
titrat
endpoint
titrat
quadrupl
vero
cell
cultur
dmem
supplement
fetal
calf
serum
mmoll
lglutamin
uml
penicillin
streptomycin
cell
inocul
serial
dilut
viru
score
cytopath
effect
day
later
median
tissu
cultur
infect
dose
tcid
calcul
method
spearmankarb
aerosol
gener
pass
air
flow
rate
lmin
collison
nebul
bgi
describ
elsewher
aerosol
thu
gener
mix
humidifi
air
flow
lmin
introduct
goldberg
drum
biaero
achiev
initi
rel
humid
initi
condit
insid
drum
temperatur
rel
humid
drum
rotat
rpm
entir
experi
includ
coat
clear
process
sampl
collect
via
pass
air
lmin
second
goldberg
drum
allglass
air
sampl
imping
ace
glass
contain
ml
dmem
supplement
fb
antifoam
sigma
humidifi
makeup
air
introduc
simultan
drum
lmin
gener
sampler
calibr
use
frictionless
bubbl
meter
gilibr
sensidyn
ensur
desir
flow
rate
pressur
achiev
airflow
humid
control
airflow
humid
temperatur
monitor
use
aeroplu
aerosol
manag
platform
aeromp
biaera
technolog
particl
size
rang
gener
aerosol
measur
use
model
aerodynam
particl
sizer
spectromet
tsi
drum
load
describ
coat
process
aerosol
dmem
fb
introduc
drum
minut
humidifi
air
pass
drum
minut
clear
flow
rate
lmin
coat
drum
load
aerosol
virusfre
medium
minut
inlet
exit
valv
close
aerosol
allow
mix
minut
end
minut
valv
open
sampl
analyz
minut
sampl
analyz
flow
rate
lmin
goldberg
drum
coat
clear
load
describ
except
collison
nebul
load
dmemfb
contain
tcid
ml
viru
sampl
collect
drum
minut
flow
lmin
humidifi
air
drum
second
viru
captur
ml
dmemfb
antifoam
allglass
air
sampl
imping
sampl
collect
quantit
reversetranscript
polymeras
chain
reaction
qrtpcr
viru
titrat
viral
rna
extract
collect
sampl
use
corbett
robot
extract
robot
qiagen
machereynagel
reagent
accord
manufactur
instruct
sampl
inactiv
avl
buffer
qiagen
absolut
ethanol
onestep
qrtpcr
target
ebola
viru
l
gene
perform
qiagen
rotorgen
q
pcr
cycler
use
quantifast
reagent
qiagen
accord
manufactur
instruct
step
qrtpcr
follow
reversetranscript
minut
initi
pcr
activ
second
follow
cycl
denatur
second
anneal
second
rna
genom
copi
number
calcul
use
vitro
transcrib
copi
section
l
gene
obtain
genom
copi
number
sampl
analyz
use
nanodrop
spectrophotomet
thermo
scientif
genom
copi
number
calcul
specif
transcript
use
beer
law
molar
absorpt
calcul
transcript
aerosol
describ
particl
suspend
air
diamet
divid
small
droplet
diamet
droplet
nuclei
minut
composit
aerosol
small
droplet
dropletnuclei
ratio
shift
droplet
nuclei
small
droplet
hour
total
concentr
particl
drop
time
period
aerosol
gener
approxim
ml
viru
concentr
tcid
ml
ebov
mayinga
ebov
makona
respect
l
humidifi
aerosol
gener
pass
drum
creat
aerosol
environ
insid
drum
viru
concentr
tcid
l
ebov
mayinga
ebov
makona
respect
ebov
rna
use
intern
control
physic
loss
aerosol
owe
sampl
settl
aerosol
cours
experi
qrtpcr
use
monitor
genom
copi
number
aerosol
viru
suspens
proxi
amount
aerosol
still
suspens
figur
viru
titrat
sampl
collect
allglass
imping
carri
microtit
plate
data
use
back
calcul
tcid
per
liter
drum
aerosol
figur
viabil
measur
normal
viral
genom
copi
remain
suspens
figur
nonlinear
regress
model
use
analyz
data
viru
slope
compar
signific
differ
slope
tcid
per
liter
aerosol
viru
regardless
whether
data
normal
rna
copi
number
data
therefor
case
nonlinear
regress
model
fit
slope
deriv
data
slope
nonlinear
regress
nonnorm
data
slope
nonlinear
regress
normal
model
use
singleslop
regress
model
gener
data
normal
genom
copi
number
time
requir
reduct
log
tcid
calcul
minut
day
valu
similar
decay
rate
report
elsewher
viru
dri
stainless
steel
plastic
day
substanc
viabl
viru
recov
aerosol
minut
averag
concentr
studi
compar
viabil
tempor
separ
strain
ebov
determin
whether
viru
becom
stabl
within
aerosol
could
potenti
increas
abil
humantohuman
transmiss
virus
ebov
mayinga
ebov
makona
aerosol
kept
suspens
goldberg
rotat
drum
sampl
collect
cours
hour
tcid
per
liter
calcul
plot
compar
slope
viabil
time
statist
signific
differ
viabil
strain
hour
held
true
regardless
whether
viabil
normal
number
rna
copi
aerosol
sampl
previou
studi
stabil
aerosol
filovirus
use
goldberg
drum
viabl
ebov
recov
minut
length
experi
direct
comparison
studi
problemat
although
tcid
report
refer
unit
volum
volum
aerosol
sampl
medium
miniimping
also
state
make
imposs
calcul
concentr
viru
aerosol
insid
drum
rate
viru
lost
viabil
aerosol
remain
virus
indic
scope
west
african
outbreak
due
increas
stabil
aerosol
viru
agreement
epidemiolog
find
show
evid
increas
transmiss
via
aerosol
rout
one
limit
low
start
titer
although
start
titer
aerosol
gener
studi
may
biolog
relev
purpos
studi
higher
start
titer
would
allow
accur
assess
loss
viru
viabil
time
second
limit
within
drum
aerosol
confin
volum
drum
necessari
paramet
studi
realworld
condit
viru
would
expect
dissip
thu
lower
concentr
time
addit
aerosol
gener
use
viru
cell
cultur
medium
bodi
fluid
would
natur
set
result
studi
suggest
abil
ebov
makona
surviv
within
aerosol
greater
ebov
mayinga
genet
distinct
tempor
separ
viru
strain
also
show
ebov
surviv
hour
aerosol
rel
humid
data
calcul
decay
rate
log
tcid
min
viru
titer
normal
rna
level
use
reflect
loss
aerosol
due
sampl
withdraw
settl
c
limit
detect
assay
log
median
tissu
cultur
infect
dose
tcid
l
slope
compar
graph
use
graphpad
analysi
covari
function
case
signific
differ
slope
reduct
viru
number
line
stabil
ebov
dri
surfac
disclaim
fund
sourc
studi
role
design
conduct
studi
collect
manag
analysi
interpret
data
prepar
review
approv
manuscript
financi
support
work
support
intramur
research
program
nation
institut
allergi
infecti
diseas
nation
institut
health
potenti
conflict
interest
author
report
conflict
author
submit
icmj
form
disclosur
potenti
conflict
interest
conflict
editor
consid
relev
content
manuscript
disclos
